C4 Therapeutics CCCC
NASDAQ CCCC
$3.17 +0.01 (+0.32%)
At close: Oct 21, 2026 · 4:00 PM EDT

C4 Therapeutics (CCCC) Long-Term Debt Repayments (2023)

Updated

C4 Therapeutics' Long-Term Debt Repayments was $12.5 million in FY2023.

Analysis

C4 Therapeutics (CCCC) Long-Term Debt Repayments (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 C4 Therapeutics 413.66 Mn -516.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 11.00 Mn
Jun 30, 2023 750,000.00
Mar 31, 2023 750,000.00
API Access

C4 Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=CCCC&period=max&api_key=YOUR_API_KEY